| Literature DB >> 31467620 |
Wei Sheng1, Youchang Huang2, Zaichun Deng1, Hongying Ma1.
Abstract
Objective: This epidemiological investigation aimed at determining the current situation regarding the diagnosis and treatment of chronic obstructive pulmonary disease (COPD), especially missed diagnosis and missed treatment, in a group of individuals residing in an island area of Ningbo.Entities:
Year: 2019 PMID: 31467620 PMCID: PMC6701409 DOI: 10.1155/2019/6918340
Source DB: PubMed Journal: Can Respir J ISSN: 1198-2241 Impact factor: 2.409
Figure 1Flow of participants through the study.
Comparison of prevalence among individuals with different factors.
| Number of cases | Prevalence rate ( |
|
| |
|---|---|---|---|---|
| Gender | 96.478 | <0.01 | ||
| Men | 682 | 197 (28.9) | ||
| Women | 689 | 57 (8.3) | ||
| Age | 55.189 | <0.01 | ||
| 60–69 years | 786 | 99 (12.6) | ||
| 70–79 years | 475 | 113 (23.8) | ||
| ≥80 years | 110 | 42 (38.2) | ||
| Smoking | 133.722 | <0.01 | ||
| Yes | 572 | 188 (32.9) | ||
| No | 799 | 66 (8.3) | ||
| Smoking (pack-years) | 150.310 | <0.01 | ||
| 0 | 799 | 66 (8.3) | ||
| 1–14.9 | 66 | 12 (18.2) | ||
| 15–29.9 | 106 | 31 (29.1) | ||
| ≥30 | 400 | 145 (36.1) | ||
| BMI | 2.654 | >0.01 | ||
| <18.5 | 56 | 14 (25.0) | ||
| 18.5–23.9 | 692 | 133 (19.2) | ||
| 24.0–27.9 | 480 | 81 (16.9) | ||
| ≥28 | 143 | 26 (18.2) | ||
| Family history of respiratory diseases | 2.659 | >0.01 | ||
| Yes | 135 | 32 (23.7) | ||
| No | 1236 | 222 (18.0) | ||
| Exposure to biomass smoke from cooking | Unable to judge | Unable to judge | ||
| Yes | 997 | 155 (15.6) | ||
| No | 374 | 99 (26.5) | ||
| Cough | 129.282 | <0.01 | ||
| Yes | 458 | 162 (35.4) | ||
| No | 913 | 92 (10.1) | ||
| Dyspnea | 114.045 | >0.01 | ||
| Level 1 | 1024 | 128 (12.5) | ||
| Level 2 | 280 | 90 (32.1) | ||
| Levels 3–5 | 67 | 36 (53.7) |
Figure 2The prevalence of COPD in different age groups and sex groups compared in a column chart.
Multivariate logistic regression analysis of residents with COPD.
| Variable | B | SE | Wald | Significant | OR value | 95% CI |
|---|---|---|---|---|---|---|
| Sex | 0.459 | 0.264 | 3.023 | 0.082 | 1.582 | (0.943, 2.655) |
| Age | 0.078 | 0.011 | 48.303 | <0.01 | 1.082 | (1.058, 1.106) |
| Smoking | −1.359 | 0.250 | 29.441 | <0.01 | 0.257 | (0.157, 0.420) |
Figure 3The ROC curve of COPD-SQ.
The relationship between factors in different sex GOLD classification.
| Men | Women | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total | NO COPD | GOLD stage I | GOLD stage II | GOLD stage III-IV | Total | No COPD | GOLD stage I | GOLD stage II | GOLD stage III-IV | |
| Age (years) | 69.7 ± 6.7 | 68.9 ± 6.3 | 70.5 ± 6.9 | 72.1 ± 6.8 | 73.5 ± 7.2 | 68.5 ± 6.0 | 68.1 ± 5.8 | 74.9 ± 6.7 | 71.0 ± 5.6 | 71.8 ± 6.4 |
| 60–69 | 366 (53.7%) | 288 (59.4%) | 40 (48.8%) | 31 (37.3%) | 8 (25.0%) | 419 (60.8%) | 399 (63.1%) | 4 (18.2%) | 12 (52.2%) | 4 (33.3%) |
| 70–79 | 246 (36.1%) | 159 (32.8%) | 30 (36.6%) | 39 (47.0%) | 17 (53.1%) | 230 (33.4%) | 203 (32.1%) | 11 (50.0%) | 9 (39.1%) | 7 (58.3%) |
| ≥80 | 70 (10.3%) | 38 (7.8%) | 12 (14.6%) | 13 (15.7%) | 7 (21.9%) | 40 (5.8%) | 30 (4.7%) | 7 (31.8%) | 2 (8.7%) | 1 (8.3%) |
|
| ||||||||||
| Smoking | ||||||||||
| Yes | 551 (80.8%) | 370 (76.3%) | 70 (85.4%) | 79 (95.2%) | 32 (100.0%) | 21 (3.0%) | 14 (2.2%) | 1 (4.5%) | 4 (17.4%) | 2 (16.7%) |
| No | 131 (19.2%) | 115 (23.7%) | 12 (14.6%) | 4 (4.8%) | 0 (0.0%) | 668 (97.0%) | 618 (97.8%) | 21 (95.5%) | 19 (82.6%) | 10 (83.3%) |
|
| ||||||||||
| Smoking (pack-years) | ||||||||||
| 0 | 131 (19.2%) | 115 (23.7%) | 12 (14.6%) | 4 (4.8%) | 0 (0.0%) | 668 (97.0%) | 618 (97.8%) | 21 (95.4%) | 19 (82.6%) | 10 (83.3%) |
| 1–14.9 | 59 (8.7%) | 48 (9.9%) | 5 (6.1%) | 6 (7.2%) | 0 (0.0%) | 7 (1.0%) | 6 (0.9%) | 0 (0.0%) | 0 (0.0%) | 1 (8.3%) |
| 15.0–29.9 | 100 (14.7%) | 70 (14.4%) | 7 (8.5%) | 17 (20.5%) | 6 (18.8%) | 6 (0.8%) | 5 (0.8%) | 0 (0.0%) | 1 (4.3%) | 0 (0.0%) |
| ≥30 | 392 (57.5%) | 252 (52.0%) | 58 (70.7%) | 56 (67.5%) | 26 (81.2%) | 8 (1.2%) | 3 (0.5%) | 1 (4.5%) | 3 (13.0%) | 1 (8.3%) |
|
| ||||||||||
| BMI | ||||||||||
| <18.5 | 28 (4.1%) | 19 (3.9%) | 1 (1.2%) | 4 (4.8%) | 4 (12.5%) | 28 (4.1%) | 23 (3.6%) | 3 (13.6%) | 2 (8.7%) | 0 (0.0%) |
| 18.5–23.9 | 372 (54.5%) | 262 (54.0%) | 49 (59.8%) | 40 (48.2%) | 21 (65.6%) | 320 (46.4%) | 297 (47.0%) | 6 (27.3%) | 11 (47.8%) | 6 (50.0%) |
| 24.0–27.9 | 231 (33.9%) | 167 (34.4%) | 28 (34.1%) | 33 (39.8%) | 3 (9.4%) | 249 (36.1%) | 232 (36.7%) | 8 (36.4%) | 7 (30.4%) | 2 (16.7%) |
| ≥28.0 | 51 (7.5%) | 37 (7.6%) | 4 (4.9%) | 6 (7.2%) | 4 (12.5%) | 92 (13.4%) | 80 (12.7%) | 5 (22.7%) | 3 (13.0%) | 4 (33.3%) |
|
| ||||||||||
| Family history of respiratory diseases | ||||||||||
| Yes | 64 (9.4%) | 38 (7.8%) | 6 (7.3%) | 13 (15.7%) | 7 (21.9%) | 71 (10.3%) | 65 (10.3%) | 2 (9.1%) | 2 (8.7%) | 2 (16.7%) |
| No | 618 (90.6%) | 447 (92.2%) | 76 (92.7%) | 70 (84.3%) | 25 (78.1%) | 618 (89.7%) | 567 (89.7%) | 20 (90.9%) | 21 (91.3%) | 10 (83.3%) |
|
| ||||||||||
| Exposure to biomass smoke from cooking | ||||||||||
| Yes | 373 (54.7%) | 269 (55.5%) | 43 (52.4%) | 42 (50.6%) | 19 (59.4%) | 624 (90.6%) | 573 (90.7%) | 19 (86.4%) | 21 (91.3%) | 11 (91.7%) |
| No | 309 (45.3%) | 216 (44.5%) | 39 (47.6%) | 41 (49.4%) | 13 (40.6%) | 65 (9.4%) | 59 (9.3%) | 3 (13.6%) | 2 (8.7%) | 1 (8.3%) |
|
| ||||||||||
| Cough | ||||||||||
| Yes | 284 (41.6%) | 154 (31.8%) | 49 (59.8%) | 54 (65.0%) | 27 (84.4%) | 174 (25.3%) | 142 (22.5%) | 9 (40.9%) | 15 (65.2%) | 8 (66.7%) |
| No | 398 (58.4%) | 331 (68.2%) | 33 (40.2%) | 29 (35.0%) | 5 (15.6%) | 515 (74.7%) | 490 (77.5%) | 13 (59.1%) | 8 (34.8%) | 4 (33.3%) |
|
| ||||||||||
| Dyspnea | ||||||||||
| Level 1 | 523 (76.7%) | 423 (87.2%) | 59 (72.0%) | 34 (41.0%) | 7 (21.9%) | 501 (72.7%) | 473 (74.8%) | 17 (77.3%) | 9 (39.1%) | 2 (16.7%) |
| Level 2 | 126 (18.5%) | 52 (10.7%) | 18 (22.0%) | 40 (48.2%) | 16 (50.0%) | 154 (22.4%) | 138 (21.8%) | 2 (9.1%) | 9 (39.1%) | 5 (41.7%) |
| Level 3–5 | 33 (4.8%) | 10 (2.1%) | 5 (6.1%) | 9 (10.8%) | 9 (28.1%) | 34 (4.9%) | 21 (3.3%) | 3 (13.6%) | 5 (21.8%) | 5 (41.7%) |
|
| ||||||||||
| mMRC | — | — | 1.3 ± 0.9 | 1.8 ± 1.0 | 2.4 ± 1.3 | — | — | 1.3 ± 1.1 | 1.4 ± 1.1 | 2.5 ± 1.6 |
| CAT | — | — | 6.1 ± 5.9 | 7.5 ± 6.1 | 13.4 ± 8.2 | — | — | 6.2 ± 5.5 | 6.8 ± 5.3 | 10.7 ± 8.5 |
| FEV1 (L) | 2.3 ± 0.6 | 2.5 ± 0.5 | 2.2 ± 0.4 | 1.6 ± 0.3 | 0.9 ± 0.3 | 1.8 ± 0.4 | 1.9 ± 0.4 | 1.5 ± 0.4 | 1.1 ± 0.2 | 0.7 ± 0.1 |
| FVC (L) | 3.1 ± 0.7 | 3.1 ± 0.6 | 3.4 ± 0.6 | 2.6 ± 0.5 | 2.0 ± 0.6 | 2.2 ± 0.5 | 2.3 ± 0.5 | 2.3 ± 0.5 | 1.8 ± 0.3 | 1.2 ± 0.2 |
Figure 4General surveys of patients with COPD. (a) COPD occupational survey. (b) COPD educational level survey. (c) COPD patients in the highest hospitals. (d) COPD patients in the highest departments.